1. Home
  2. SCNI vs JWEL Comparison

SCNI vs JWEL Comparison

Compare SCNI & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • JWEL
  • Stock Information
  • Founded
  • SCNI 2003
  • JWEL 2012
  • Country
  • SCNI Israel
  • JWEL China
  • Employees
  • SCNI N/A
  • JWEL N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • JWEL Other Consumer Services
  • Sector
  • SCNI Health Care
  • JWEL Consumer Discretionary
  • Exchange
  • SCNI Nasdaq
  • JWEL Nasdaq
  • Market Cap
  • SCNI 3.5M
  • JWEL 4.1M
  • IPO Year
  • SCNI N/A
  • JWEL 2021
  • Fundamental
  • Price
  • SCNI $3.48
  • JWEL $2.54
  • Analyst Decision
  • SCNI
  • JWEL
  • Analyst Count
  • SCNI 0
  • JWEL 0
  • Target Price
  • SCNI N/A
  • JWEL N/A
  • AVG Volume (30 Days)
  • SCNI 13.2K
  • JWEL 881.8K
  • Earning Date
  • SCNI 11-22-2024
  • JWEL 12-27-2024
  • Dividend Yield
  • SCNI N/A
  • JWEL N/A
  • EPS Growth
  • SCNI N/A
  • JWEL N/A
  • EPS
  • SCNI 8.20
  • JWEL N/A
  • Revenue
  • SCNI $452,000.00
  • JWEL $160,009,293.00
  • Revenue This Year
  • SCNI N/A
  • JWEL N/A
  • Revenue Next Year
  • SCNI N/A
  • JWEL N/A
  • P/E Ratio
  • SCNI $0.42
  • JWEL N/A
  • Revenue Growth
  • SCNI N/A
  • JWEL N/A
  • 52 Week Low
  • SCNI $2.23
  • JWEL $1.00
  • 52 Week High
  • SCNI $8.92
  • JWEL $3.71
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 56.32
  • JWEL 44.78
  • Support Level
  • SCNI $3.20
  • JWEL $2.45
  • Resistance Level
  • SCNI $3.55
  • JWEL $3.13
  • Average True Range (ATR)
  • SCNI 0.18
  • JWEL 0.36
  • MACD
  • SCNI 0.03
  • JWEL -0.11
  • Stochastic Oscillator
  • SCNI 51.72
  • JWEL 3.67

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.

Share on Social Networks: